Related references
Note: Only part of the references are listed.Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)
Philip Wing-Lok Ho et al.
AUTOPHAGY (2020)
Expert comment: A case of missing pathology in a patient with LRRK2 Parkinson's disease
Lorraine V. Kalia
PARKINSONISM & RELATED DISORDERS (2020)
Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease
Julian Agin-Liebes et al.
PARKINSONISM & RELATED DISORDERS (2020)
Initiation and propagation of α-synuclein aggregation in the nervous system
Baraa A. Hijaz et al.
MOLECULAR NEURODEGENERATION (2020)
The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System
Tomoki Kuwahara et al.
FRONTIERS IN NEUROSCIENCE (2020)
Genetics of Parkinson's disease: An introspection of its journey towards precision medicine
Sara Bandres-Ciga et al.
NEUROBIOLOGY OF DISEASE (2020)
The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A
Pilar Rivero-Rios et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri et al.
ACTA NEUROPATHOLOGICA (2019)
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
Sarah H. Shahmoradian et al.
NATURE NEUROSCIENCE (2019)
Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients
Belen Fernandez et al.
BIOCHEMICAL JOURNAL (2019)
Structural Insights into the Regulation Mechanism of Small GTPases by GEFs
Sachiko Toma-Fukai et al.
MOLECULES (2019)
Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects
Pascale Barbier et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
Bilal R. Malik et al.
MOLECULAR BRAIN (2019)
Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease
Michael X. Henderson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
LRRK2 and membrane trafficking: nexus of Parkinson's disease
Eun-Mi Hur et al.
BMB REPORTS (2019)
P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity
Alexia F. Kalogeropulou et al.
BIOCHEMICAL JOURNAL (2018)
Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo
Elena Kozina et al.
BRAIN (2018)
Rab GTPases and Membrane Trafficking in Neurodegeneration
Ferdi Ridvan Kiral et al.
CURRENT BIOLOGY (2018)
Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation
Jesus Madero-Perez et al.
MOLECULAR NEURODEGENERATION (2018)
Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration
Ga Ram Jeong et al.
MOLECULAR NEURODEGENERATION (2018)
Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice
Yulan Xiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease
Maria Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
G2019S LRRK2 mutation facilitates alpha-synuclein neuropathology in aged mice
Salvatore Novello et al.
NEUROBIOLOGY OF DISEASE (2018)
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LRRK2 kinase regulates alpha-synuclein propagation via RAB35 phosphorylation
Eun-Jin Bae et al.
NATURE COMMUNICATIONS (2018)
Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease
Silke Nuber et al.
NEURON (2018)
A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
Herschel S. Dhekne et al.
ELIFE (2018)
Tau in neurodegenerative disease
Yong-Lei Gao et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Neuropathology of Genetic Synucleinopathies With Parkinsonism: Review of the Literature
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2017)
The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse
F. Giesert et al.
NEUROBIOLOGY OF DISEASE (2017)
A homologue of the Parkinson's disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
Egon Deyaert et al.
NATURE COMMUNICATIONS (2017)
Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice
Mantia Karampetsou et al.
SCIENTIFIC REPORTS (2017)
The GTPase Rab43 Controls the Anterograde ER-Golgi Trafficking and Sorting of GPCRs
Chunman Li et al.
CELL REPORTS (2017)
Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis
Martin Steger et al.
ELIFE (2017)
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
Francesco Longo et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease
Heyne Lee et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Tau and neurodegenerative disease: the story so far
Khalid Iqbal et al.
NATURE REVIEWS NEUROLOGY (2016)
(R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model
Yi-Hsin Weng et al.
EXPERIMENTAL NEUROLOGY (2016)
Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease
Md Shariful Islam et al.
HUMAN MOLECULAR GENETICS (2016)
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate
Elisa Belluzzi et al.
MOLECULAR NEURODEGENERATION (2016)
Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts
Giambattista Guaitoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Increased Rab35 expression is a potential biomarker and implicated in the pathogenesis of Parkinson's disease
Ching-Chi Chiu et al.
ONCOTARGET (2016)
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger et al.
ELIFE (2016)
Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate
Petranka Krumova et al.
FASEB JOURNAL (2015)
An early endosome regulator, Rab5b, is an LRRK2 kinase substrate
Hye Jin Yun et al.
JOURNAL OF BIOCHEMISTRY (2015)
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
M. Yue et al.
NEUROBIOLOGY OF DISEASE (2015)
Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease
Elpida Tsika et al.
NEUROBIOLOGY OF DISEASE (2015)
Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
Ulf Dettmer et al.
NATURE COMMUNICATIONS (2015)
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Lorraine V. Kalia et al.
JAMA NEUROLOGY (2015)
LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism
Amaia M. Arranz et al.
JOURNAL OF CELL SCIENCE (2015)
Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson's Disease
Ian Martin et al.
CELL (2014)
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity
Julien Dusonchet et al.
HUMAN MOLECULAR GENETICS (2014)
The Parkinson Disease-linked LRRK2 Protein Mutation I2020T Stabilizes an Active State Conformation Leading to Increased Kinase Activity
Soumya Ray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse
Jun-Shiao Chou et al.
NEUROBIOLOGY OF DISEASE (2014)
Parkinson disease-associated mutation R1441H in LRRK2 prolongs the active state of its GTPase domain
Jingling Liao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
Jan O. Aasly et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2
Alice Biosa et al.
HUMAN MOLECULAR GENETICS (2013)
Dopaminergic expression of the Parkinsonian gene LRRK2-G2019S leads to non-autonomous visual neurodegeneration, accelerated by increased neural demands for energy
Samantha Hindle et al.
HUMAN MOLECULAR GENETICS (2013)
The Lewy Body in Parkinson's Disease and Related Neurodegenerative Disorders
Koichi Wakabayashi et al.
MOLECULAR NEUROBIOLOGY (2013)
Non-Motor and Motor Features in LRRK2 Transgenic Mice
Zoe Bichler et al.
PLOS ONE (2013)
LRRK2: Cause, Risk, and Mechanism
Coro Paisan-Ruiz et al.
JOURNAL OF PARKINSONS DISEASE (2013)
LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25
Hye Jin Yun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport
Eric C. Freundt et al.
ANNALS OF NEUROLOGY (2012)
(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD
C-Y Chen et al.
CELL DEATH AND DIFFERENTIATION (2012)
Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning
Mark W. Dodson et al.
HUMAN MOLECULAR GENETICS (2012)
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1
Xinglong Wang et al.
HUMAN MOLECULAR GENETICS (2012)
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
Kelvin C. Luk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Clinical and Pathological Characteristics of LRRK2 G2019S Patients with PD
Markos Poulopoulos et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein
Jingwen Niu et al.
JOURNAL OF NEUROCHEMISTRY (2012)
ArfGAP1 Is a GTPase Activating Protein for LRRK2: Reciprocal Regulation of ArfGAP1 by LRRK2
Yulan Xiong et al.
JOURNAL OF NEUROSCIENCE (2012)
The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities
Tatsunori Maekawa et al.
MOLECULAR NEURODEGENERATION (2012)
Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway
Youren Tong et al.
MOLECULAR NEURODEGENERATION (2012)
LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
Samer Matta et al.
NEURON (2012)
LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
Fumitaka Kawakami et al.
PLOS ONE (2012)
Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers
Laura Civiero et al.
PLOS ONE (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease
Byoung Dae Lee et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
GTPase Activity and Neuronal Toxicity of Parkinson's Disease-Associated LRRK2 Is Regulated by ArfGAP1
Klodjan Stafa et al.
PLOS GENETICS (2012)
Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson's Disease-Related Toxicity in Human Neurons
Nigel Ramsden et al.
ACS CHEMICAL BIOLOGY (2011)
α-Synuclein Aggregation and Transmission Are Enhanced by Leucine-Rich Repeat Kinase 2 in Human Neuroblastoma SH-SY5Y Cells
Kazunari Kondo et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
Martin C. Herzig et al.
HUMAN MOLECULAR GENETICS (2011)
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
Zhaohui Liu et al.
HUMAN MOLECULAR GENETICS (2011)
Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
Philip J. Webber et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
Veronique Daniels et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Learning PD from the Lark
Shyamal H. Mehta et al.
MOVEMENT DISORDERS (2011)
Role of Rab GTPases in Membrane Traffic and Cell Physiology
Alex H. Hutagalung et al.
PHYSIOLOGICAL REVIEWS (2011)
Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation
Zdenek Berger et al.
BIOCHEMISTRY (2010)
Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila
Tomoko Kanao et al.
HUMAN MOLECULAR GENETICS (2010)
Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C
Chieh Hsu et al.
JOURNAL OF CELL BIOLOGY (2010)
LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of the Drosophila Neuromuscular Junction
Seongsoo Lee et al.
JOURNAL OF NEUROSCIENCE (2010)
LRRK2 G2019S Mutation Induces Dendrite Degeneration through Mislocalization and Phosphorylation of Tau by Recruiting Autoactivated GSK3β
Chin-Hsien Lin et al.
JOURNAL OF NEUROSCIENCE (2010)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
Christian Johannes Gloeckner et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
Chen Yao et al.
NEUROBIOLOGY OF DISEASE (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Christian Wider et al.
NEURODEGENERATIVE DISEASES (2010)
ARHGEF7 (BETA-PIX) Acts as Guanine Nucleotide Exchange Factor for Leucine-Rich Repeat Kinase 2
Karina Haebig et al.
PLOS ONE (2010)
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
Elisa Greggio et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
Katerina Venderova et al.
HUMAN MOLECULAR GENETICS (2009)
Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization
Saurabh Sen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration?
Frank Gillardon
JOURNAL OF NEUROCHEMISTRY (2009)
Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
Loukia Parisiadou et al.
JOURNAL OF NEUROSCIENCE (2009)
Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
Chee-Hoe Ng et al.
JOURNAL OF NEUROSCIENCE (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
Xian Lin et al.
NEURON (2009)
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
Kelvin C. Luk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Yuzuru Imai et al.
EMBO JOURNAL (2008)
Non-motor symptoms in Parkinson's disease
W. Poewe
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Proteomic identification of novel proteins associated with Lewy bodies
Qiangwei Xia
Frontiers in Bioscience-Landmark (2008)
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein
He-Jin Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
Elisa Greggio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis
Aaron D. Gitler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
Proteomic identification of novel proteins in cortical Lewy bodies
James B. Leverenz et al.
BRAIN PATHOLOGY (2007)
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
Genta Ito et al.
BIOCHEMISTRY (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
LRRK2 protein is a component of Lewy bodies
Xiongwei Zhu et al.
ANNALS OF NEUROLOGY (2006)
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
A. Rajput et al.
NEUROLOGY (2006)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
LRRK2 expression in normal and pathologic human brain and in human cell lines
Judith Miklossy et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Rab35 regulates an endocytic recycling pathwav essential for the terminal steps of cytokinesis
Ilektra Kouranti et al.
CURRENT BIOLOGY (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
Antony A. Cooper et al.
SCIENCE (2006)
PINK1 protein in normal human brain and Parkinson's disease
S. Gandhi et al.
BRAIN (2006)
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease
J Infante et al.
NEUROSCIENCE LETTERS (2006)
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
CJ Gloeckner et al.
HUMAN MOLECULAR GENETICS (2006)
G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort
JM Bras et al.
MOVEMENT DISORDERS (2005)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Intravesicular localization and exocytosis of α-synuclein and its aggregates
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Clinical features of LRRK2-associated Parkinson's disease in Central Norway
JO Aasly et al.
ANNALS OF NEUROLOGY (2005)
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations
J Kachergus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease
JH Jin et al.
MOLECULAR BRAIN RESEARCH (2005)
Role of tau protein in both physiological and pathological conditions
J Avila et al.
PHYSIOLOGICAL REVIEWS (2004)
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease
R Bandopadhyay et al.
BRAIN (2004)
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
MM Ponsen et al.
ANNALS OF NEUROLOGY (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes
TT Ding et al.
BIOCHEMISTRY (2002)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies
MG Schlossmacher et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
